Original Article

European Journal of Clinical Nutrition (2011) 65, 1027–1031; doi:10.1038/ejcn.2011.62; published online 11 May 2011

Dairy consumption and risk of type 2 diabetes mellitus: a meta-analysis of cohort studies

X Tong1, J-Y Dong1, Z-W Wu1, W Li1 and L-Q Qin1

1Department of Nutrition and Food Hygiene, School of Radiation Medicine and Public Health, Soochow University, Suzhou, China

Correspondence: Dr L-Q Qin, Department of Nutrition and Food Hygiene, School of Radiation Medicine and Public Health, Soochow University, Renai Road 199, Suzhou Industrial Park, Suzhou 215123, China. E-mail: qinliqiang@suda.edu.cn

Received 23 August 2010; Revised 1 March 2011; Accepted 9 March 2011; Published online 11 May 2011.

Contributors: L-QQ designed this article and supported the research. XT collected the data and performed the statistical analysis. J-YD assisted the statistical analysis. Z-WW and WL assisted the collection of data. All authors read and approved this article.





Milk intake is widely recommended for a healthy diet. Epidemiological studies have suggested that the consumption of dairy products may be associated with a reduction in type 2 diabetes mellitus (T2DM). A meta-analysis was conducted to elucidate the association between dairy products consumption and T2DM.



A systematical literature search was done through the Medline database and seven related cohort studies were identified. The adjusted relative risks (RRs) with the highest and the lowest categories from each study were extracted to calculate the combined RR. A least-square trend estimation was applied to assess the dose-response relationships.



A combined RR of 0.86 (95% confidence interval (CI), 0.79–0.92) was revealed on T2DM risk associated to dairy intake, with little evidence of heterogeneity. For subgroup analysis, a combined RR was 0.82 (95% CI, 0.74–0.90), 1.00 (95% CI, 0.89–1.10), 0.95 (95% CI, 0.86–1.05) and 0.83 (95% CI, 0.74–0.93) for the intake of low-fat dairy, high-fat dairy, whole milk and yogurt, respectively. Dose-response analysis showed that T2DM risk could be reduced 5% for total dairy products and 10% for low-fat dairy products.



An inverse association of daily intake of dairy products, especially low-fat dairy, with T2DM was revealed, indicating a beneficial effect of dairy consumption in the prevention of T2DM development.


dairy products; type 2 diabetes mellitus; meta-analysis



The world prevalence of type 2 diabetes mellitus (T2DM) is increasing at an alarming rate. T2DM affects approximately 190 million people worldwide and it is very likely to increase to 366 million by 2030 (Wild et al., 2004). Epidemiological data suggest that the prevalence will continue to increase globally without effective prevention and control (Alberti et al., 2007). Human studies have shown that diet and lifestyle modifications may have an important role in preventing T2DM (Eriksson and Lindgarde, 1991; Lindstrom et al., 2003).

In recent years, the role of dairy products in the etiology of T2DM has created considerable attention in research fields. Some cohort studies aiming at examining the relationship between the intake of dairy products and T2DM observed a significantly inverse association, but others showed negative results. Some factors related to the dairy components have been assumed to modify the effect of dairy intake on T2DM, such as the type and fat level of the dairy products, as well as the amount of daily consumption. Although a recent review reported the prevention of dairy intake to T2DM (Pittas et al., 2007), these factors have not been included. To clarify the mechanism by which dairy consumption prevents human from T2DM, it is reasonable to examine the association between these factors and T2DM risk, using a meta-analysis of cohort studies.


Materials and methods

The literature search was conducted with the Medline database through April 2010, using the English terms in combination of milk/dairy products and T2DM, with extended search on diet and T2DM. References listed in the searched papers were used for additional screening of relevant data.

A study was included as a candidate if it met the following criteria: (1) The paper presented original data from a cohort study. (2) Among multiple publications based on the same population study or the same results published in different journals, only the most recent one would be included for the analysis. (3) Whole milk, yogurt, low-fat dairy or high-fat dairy foods were not included in the analysis of ‘dairy products’ if they were presented individually. However, a combined relative risk (RR) would be calculated if they were observed as an independent item in more than three studies. To avoid confusion, ‘dairy’ and ‘total dairy foods’ used in the original studies were termed as ‘dairy products’ and ‘milk’ as ‘whole milk’ in this meta-analysis. (4) RR and its 95% confidence interval (95% CI) were provided, or raw data were available in the paper for calculating these parameters. (5) The RR and the corresponding 95% CI extracted from the literature were compared to obtain the highest and the lowest amount of dairy consumption. When more than one risk estimates presented, the one adjusted for the greatest number of potential confounders was used to meet with the optimal control of confounding factors.

Communication letters, abstracts and conference proceedings published in non-peer-reviewed journals, and participants with type 2 diabetes at baseline were excluded for analysis to avoid bias.

Data extracted from the selected papers included the name of the first author, publication year, gender, study design, location of the study, duration of follow-up, sample size, adjustments and risk estimates with 95% CI.

Combined RR was calculated using the ‘META’ command in the Stata statistical software package (version, 8.0, Stata Corporation, College Station, TX, USA). Statistical heterogeneity among studies was assessed using the Q statistic. P-value <0.10 was considered as heterogeneous and random effects models were selected for statistics. We also examined I2 statistic, which measures the percentage of the total variation across studies that is due to heterogeneity, rather than chance (Higgins and Thompson, 2002). In addition, we conducted a sensitivity analysis to investigate the influence of a single study on the overall risk estimate by omitting one study in each turn. A dose-response analysis is performed on the basis of the data for categories of dairy products intake levels on median dose, number of cases and participants and adjusted logarithm of the RR with its SE using the ‘GLST’ command in Stata software package (Greenland and Longnecker, 1992). This analysis was restricted to the studies reporting three or more exposure levels. For different units used in individual studies, we chose serving, used by most studies, as the standard unit of measure to express the daily dairy products consumption. When the median intake value was not reported, we used the midpoint of each category. For an open-ended upper category of intake, the intake amount was estimated by assuming the same amplitude as the previous category.

Publication bias was assessed by two formal tests: the Begg-adjusted rank correlation test (Begg and Mazumdar, 1994) and the Egger's regression asymmetry test (Egger et al., 1997). If a potential bias was detected, we further conducted a sensitivity analysis to assess the robustness of combined effect estimates and the possible influence of the bias.



A total of seven publications with cohort studies (Choi et al., 2005; Liu et al., 2006; Pittas et al., 2006; van Dam et al., 2006; Elwood et al., 2007; Kirii et al., 2009; Villegas et al., 2009) on dairy and milk consumption and T2DM were included according to the criteria (Table 1). In the study by Kirii et al. (2009), participants were divided to men and women for observation. Thus, it was considered two studies when the observed items were combined. Among these studies, dairy products appeared as items in six studies (Choi et al., 2005; Liu et al., 2006; Pittas et al., 2006; van Dam et al., 2006; Elwood et al., 2007; Kirii et al., 2009), low-fat and high-fat dairy foods appeared in three studies (Choi et al., 2005; Liu et al., 2006; van Dam et al., 2006), whole milk appeared in four studies (Choi et al., 2005; Liu et al., 2006; Kirii et al., 2009; Villegas et al., 2009) and yogurt appeared in three studies (Choi et al., 2005; Liu et al., 2006; Kirii et al., 2009).

When we compared the highest with the lowest dairy products intake, the combined RR was 0.86 (95% CI, 0.79–0.92), with little evidence of heterogeneity (Q=8.53, P=0.20; I2=29.7%) (Figure 1). The test for publication bias yielded a P-value of 0.26 by Begg test and a P-value of 0.20 by Egger test. The sensitivity analyses omitting one study at a time and calculating the combined RRs for the remaining studies yielded consistent results, with a narrow range from 0.85 (95% CI, 0.77–0.93) to 0.88 (95% CI, 0.82–0.96). Thus, any single study did not appear to substantially influence the combined risk estimate.

Figure 1.
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Estimated RRs (highest versus lowest category) of T2DM associated with dairy products consumption. Tests for heterogeneity between all studies, Q=8.53, P=0.20, I2=29.7%.

Full figure and legend (54K)

In the subgroup analysis stratified by sex, the combined RR for the highest versus lowest quartiles of dairy intake was 0.86 (95% CI, 0.79–0.93) in women, whereas in men, the combined RR was 0.89 (95% CI 0.56, 1.21).

Considering fat level of dairy products, analysis on low-fat and high-fat dairy foods consumption yielded a combined RR of 0.82 (95% CI, 0.74–0.90) and 1.00 (95% CI, 0.89–1.10), respectively. For the type of products, the combined RR was 0.95 (95% CI, 0.86–1.05) in the studies reported, RR estimates for whole milk consumption and risk of T2DM and 0.83 (95% CI, 0.74–0.93) in the studies observing yogurt consumption (Table 2).

Three cohort studies (Choi et al., 2005; Liu et al., 2006; van Dam et al., 2006) were included in the dose-response analysis of the association between dairy products, low-fat and high-fat dairy foods intake and risk of T2DM. The combined RR for an increment of one serving per day was 0.94 (95% CI, 0.92–0.97) for total dairy consumption, 0.90 (95% CI, 0.85–0.95) for low-fat dairy foods and 0.98 (95% CI, 0.92–1.05) for high-fat dairy foods.

Statistical test gave rise to no evidence of publication bias with regard to consumption of dairy and milk and T2DM risk.



The result of the present analysis revealed a 14% reduction in T2DM risk in population with highest consumption of dairy products compared with the lowest intake. In the recent meta-analysis focusing on the consumption of milk and dairy foods and incidence of vascular disease, the reduction in the consumption of milk and dairy foods in diabetes was referred and not further analysis and discussion (Elwood et al., 2010). Our analysis included two more updated cohort studies and analyzed the different kinds of dairy and dose-response relationship.

In the subgroup analysis, consumption of low-fat dairy foods was found to be associated with a significantly lower risk of 18% in T2DM development. However, intake of high-fat dairy foods and whole milk was not associated with the risk of T2DM. The dose-response analysis also showed that the T2DM risk significantly lowered by 10% with one serving per day increment for low-fat dairy foods. However, dose-response relationship was insignificant for high-fat dairy foods. The weak association between high-fat dairy foods intake and T2DM in our study can be, at least partly, explained by the high-fat dairy foods contributing considerable fat to dietary intake. Some epidemiological studies have shown that consumption of diets high in saturated fat is associated with obesity and increased prevalence of diabetes (van Dam et al., 2002; Thanopoulou et al., 2003). Thus, the protective effect may largely due to other nutrients in milk and its products.

In Pittas et al.'s (2006) study, the inverse association between dairy products consumption and risk of T2DM appeared to be insignificant after adjusting for calcium and vitamin D, suggesting an effect of calcium and vitamin D on the prevention of diabetes. There are several potential mechanisms for the effects of calcium and vitamin D on T2DM. Calcium provided by dairy products could decrease accumulation of body fat and accelerate weight and fat loss during energy restriction (Zemel et al., 2000; Zemel, 2004). Additionally, calcium intake may increase fat oxidation, suppress adipose tissue oxidative and inflammatory stress, whereas adequate vitamin D may enhance the thermic effect of a meal and fat oxidation (Teegarden et al., 2008; Zemel and Sun, 2008).

On the other hand, Liu et al.'s (2006) study found that the association remained unchanged after adjusting for calcium and vitamin D. Thus, aside from calcium and vitamin D, there could be other major components in dairy products having a potential role in lowering the risk of T2DM. Recently, milk proteins, such as whey proteins, attracted increasing attention. It may enhance satiety and reduce the risk of overweight, high blood pressure and obesity, which are major risk factors for T2DM (Luhovyy et al., 2007). In animal study, whey protein was observed to enhance the insulin sensitivity (Belobrajdic et al., 2004). As insulin resistance is a pathologic basis in T2DM, the insulinotropic effects of whey proteins are prone to have an important role in preventing T2DM. Furthermore, in addition to milk proteins, trans-palmitoleate, which is obtained primarily from dairy intake, was associated with a lower incidence of diabetes. This finding supported a role of trans-palmitoleate in previously observed metabolic benefits of dairy consumption. So trans-palmitoleate may also have a beneficial effect on T2DM (Mozaffarian et al., 2010).

In addition, other factors, including sex, body mass index and age, are worth considering. Our analysis found an inverse association between dairy intake and the risk of T2DM in women, but not in men. Because evidence is limited, to explain this sex-related difference is challenging. In Kirii et al.'s (2009) study, women consumed greater amounts of dairy products than men, which may be one possible explanation. Among the included studies, two (Choi et al., 2005; Liu et al., 2006) have assessed the influence of body mass index on the association between dairy consumption and risk of T2DM, but no effect modification by body mass index was found. As for age, all included cohort studies have adjusted for this important confounder. However, none of them examined the effect modification by age on the dairy and T2DM association. Therefore, whether age has potential impacts on the association remains unclear.

Several potential limitations are worth considering in this study. First, the publication bias cannot be completely excluded. However, no evidence of publication bias was observed by statistical tests. Second, the definition of dairy products was ambiguous in some studies and components in dairy products may be different according to countries. Thus, we analyzed whole milk and dairy foods classified by fat content, which should be less heterogeneous than dairy foods as total. In this subgroup analysis, we found that fat in dairy foods masked the protective effect of milk and its products on T2DM. Third, the efficiency of analysis was limited, because some items were combined from only three or four studies. Fourth, as only seven studies were included in this meta-analysis, the combined risk estimate may be affected by individual studies, especially the one weighted the highest (Pittas et al., 2006). Yet, the consistent results from the sensitivity analyses indicated a somewhat high degree of robustness of our findings. Finally, although a wide range of potential confounding factors was controlled in original studies, we still could not exclude the possibility that uncontrolled confounding factors could affect the association. Further studies with adequate control for potential confounders are needed to confirm the findings.

In conclusion, our findings indicated an inverse association of daily intake of dairy products with T2DM, suggesting a beneficial effect of dairy consumption in the prevention of T2DM.


Conflict of interest

The authors declare no conflict of interest.



  1. Alberti KG, Zimmet P, Shaw J (2007). International diabetes federation: a consensus on type 2 diabetes prevention. Diabet Med 24, 451–463. | Article | PubMed | ISI | ChemPort |
  2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101. | Article | PubMed | ISI | ChemPort |
  3. Belobrajdic DP, McIntosh GH, Owens JA (2004). A high-whey-protein diet reduces body weight gain and alters insulin sensitivity relative to red meat in wistar rats. J Nutr 134, 1454–1458. | PubMed | ISI |
  4. Choi HK, Willett WC, Stampfer MJ, Rimm E, Hu FB (2005). Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med 165, 997–1003. | Article | PubMed | ISI |
  5. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634. | PubMed | ISI | ChemPort |
  6. Elwood PC, Pickering JE, Fehily AM (2007). Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study. J Epidemiol Community Health 61, 695–698. | Article | PubMed | ISI |
  7. Elwood PC, Pickering JE, Givens DI, Gallacher JE (2010). The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids 45, 925–939. | Article | PubMed | ISI |
  8. Eriksson KF, Lindgarde F (1991). Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 34, 891–898. | Article | PubMed | ISI | ChemPort |
  9. Greenland S, Longnecker MP (1992). Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135, 1301–1309. | PubMed | ISI | ChemPort |
  10. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med 21, 1539–1558. | Article | PubMed | ISI |
  11. Kirii K, Mizoue T, Iso H, Takahashi Y, Kato M, Inoue M et al. (2009). Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 52, 2542–2550. | Article | PubMed | ISI |
  12. Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J et al. (2003). The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 26, 3230–3236. | Article | PubMed | ISI |
  13. Liu S, Choi HK, Ford E, Song Y, Klevak A, Buring JE et al. (2006). A prospective study of dairy intake and the risk of type 2 diabetes in women. Diabetes Care 29, 1579–1584. | Article | PubMed | ISI |
  14. Luhovyy BL, Akhavan T, Anderson GH (2007). Whey proteins in the regulation of food intake and satiety. J Am Coll Nutr 26, 704S–712S. | PubMed | ISI | ChemPort |
  15. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS et al. (2010). Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in US adults: a cohort study. Ann Intern Med 153, 790–799. | PubMed | ISI |
  16. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE et al. (2006). Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 29, 650–656. | Article | PubMed | ISI | ChemPort |
  17. Pittas AG, Lau J, Hu FB, Dawson-Hughes B (2007). The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017–2029. | Article | PubMed | ISI | ChemPort |
  18. Teegarden D, White KM, Lyle RM, Zemel MB, Van Loan MD, Matkovic V et al. (2008). Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 16, 1566–1572. | Article | PubMed |
  19. Thanopoulou AC, Karamanos BG, Angelico FV, Assaad-Khalil SH, Barbato AF, Del Ben MP et al. (2003). Dietary fat intake as risk factor for the development of diabetes: multinational, multicenter study of the Mediterranean Group for the Study of Diabetes (MGSD). Diabetes Care 26, 302–307. | Article | PubMed | ISI |
  20. van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR (2006). Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in US black women. Diabetes Care 29, 2238–2243. | Article | PubMed | ISI | ChemPort |
  21. van Dam RM, Willett WC, Rimm EB, Stampfer MJ, Hu FB (2002). Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 25, 417–424. | Article | PubMed | ISI |
  22. Villegas R, Gao YT, Dai Q, Yang G, Cai H, Li H et al. (2009). Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study. Am J Clin Nutr 89, 1059–1067. | Article | PubMed | ISI | ChemPort |
  23. Wild S, Roglic G, Green A, Sicree R, King H (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053. | Article | PubMed | ISI |
  24. Zemel MB (2004). Role of calcium and dairy products in energy partitioning and weight management. Am J Clin Nutr 79, 907S–912S. | PubMed | ChemPort |
  25. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC (2000). Regulation of adiposity by dietary calcium. FASEB J 14, 1132–1138. | PubMed | ISI | ChemPort |
  26. Zemel MB, Sun X (2008). Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans. J Nutr 138, 1047–1052. | PubMed | ISI |


This research was supported in part by a grant from National Natural Science Foundation of China (No. 30771808) to Dr Li-Qiang Qin.

Extra navigation